Innovation Portfolio

Acrannolife Genomics develops genomic and pharmacogenomic diagnostics for early disease detection and preventive healthcare. Its solutions include Trunome Liquid Biopsy, a non-invasive blood test for early detection of solid organ transplant rejection across kidney, liver, heart, lung, and pancreas transplants; TB-FYND, an RT-LAMP-based tuberculosis screening test for fast and reliable early TB detection; and CoviQwik, a rapid, accurate, cost-effective COVID-19 test using RT-LAMP technology to make advanced diagnostics more accessible

HeaLink is an ABDM-aligned digital health platform offering an ABHA-linked Smart Health Card powered by NFC and QR technology. It gives individuals a portable digital health identity for secure access to electronic health records, OPD benefits, emergency information, and institutional healthcare services. Its OPD-focused HMIS supports schools, universities, and workplace health centres, while the mobile app enables users and families to access records, book appointments, track vaccinations, and manage family health profiles.

Janitri Innovations develops advanced maternal, fetal, and neonatal monitoring solutions to reduce mortality during pregnancy and childbirth. Its Keyar DT Max Plus is a CDSCO-approved, portable, smart, wireless cardiotocography device for real-time maternal and fetal monitoring during labour with seamless data transmission. The solution supports remote and central monitoring, digital partograph, labour scoring, critical alerts, continuous fetal and maternal vitals tracking, shock index, and auto-generated interpreted reports.

Medprime Technologies develops digital microscopy and whole-slide imaging solutions that improve diagnostic accuracy, pathology workflows, and medical education. Its flagship products, including the patented Cilika Microscope and Micalys AI-ready whole-slide scanner and digital microscope, enable high-quality slide visualization, scanning, analysis, remote pathology, collaborative diagnosis, and digital archiving across medical colleges, diagnostic laboratories, and tertiary hospitals.

Mobilab delivers portable, decentralized diagnostics that bring lab-quality testing to the doorstep, supporting early detection, timely intervention, and better access in remote areas. Its mobile diagnostic kits and AI-driven analysis enable rapid screening for diabetes, kidney and liver function, infectious diseases including malaria, dengue, TB, HIV, and COVID-19, and cardiac markers such as lipid profile, cholesterol, and troponin. The solution combines high accuracy, ease of use, portability, smartphone app integration, real-time monitoring, and remote cardiac assessment.

Ramja Genosensor’s PrathamaSense is a CDSCO-approved, patented DNA biosensor platform for rapid detection of infectious diseases and antimicrobial resistance directly from patient samples within 90 minutes, without culture or PCR. Clinically validated on 1,400+ samples at AIIMS with >92% sensitivity and >94% specificity, the portable, tablet-enabled platform supports 24+ infection panels to enable timely diagnostics, antibiotic stewardship, and improved patient outcomes.

Regenosca advances soft tissue regeneration through its patented TissueSpan™ technology: a fully engineered, natural, customizable collagen-based mesh for soft tissue repair. Designed for high biocompatibility and off-the-shelf surgical use, TissueSpan has shown successful preclinical and early clinical outcomes in urethral reconstruction, promoting regeneration over scarring for improved recovery.

Sunfox Technologies develops affordable cardiac diagnostics and patient monitoring solutions to strengthen cardiac care. Its flagship product, Spandan, is a portable, smartphone-enabled 12-lead ECG device for early cardiovascular disease detection, especially in low-resource and primary healthcare settings, with ECG reports available within 10 minutes. It offers high accuracy, ease of use, portability, smartphone app integration, real-time monitoring, and remote cardiac assessment for timely intervention. Spandan represented India at the World Economic Forum in China and was ranked among the top 6 new champion startups in India and 96 globally.

Thermaissance develops AI-enabled, non-invasive thermal imaging solutions for early disease detection and clinical screening. Its infrared thermography platform identifies abnormal thermal patterns linked to breast cancer, diabetic foot complications, vascular disorders, and inflammation-related diseases. Safe, radiation-free, and contactless, the solution supports rapid screening and timely intervention across hospitals, diagnostic centres, screening programmes, and primary healthcare settings.

Wysa is an India-born AI mental health platform combining CBT-based chat support, self-help tools, and expert-led coaching to build resilience and manage stress. It supports 6.5M+ users in 95 countries, is trusted by the NHS, US Air Force, and Government of Singapore, and is backed by 40+ peer-reviewed studies. Its Phygital Dream Kit combines a workbook, AI chatbot, in-person sessions, and teacher capacity-building to support adolescent girls’ emotional wellbeing and life skills across schools in India.

Xact Diagnotek develops next-generation molecular and immunodiagnostic platforms for infectious diseases, antimicrobial resistance, and zoonotic infections. Its proprietary SelektaDx™ and RAR-ELISA™ technologies offer rapid, accurate, field-deployable diagnostics for early detection and stronger human and veterinary disease surveillance, especially in resource-limited settings.